For comments, suggestions
Created with Raphaël 2.1.0 16.06.2011 Formal examination (assignment of filing date) 16.09.2011 Preliminary and substantive examination 31.12.2012 Publication of the decision of grant (B1) 30.06.2013 Completion of the opposition filing period 31.07.2013 Issuance of patent (C1) 16.06.2016 Valid until 31.01.2018 Publication of the decision of forfeiture, the term of re-establishment has expired

Patent lapsed


(11)Number of the document4190
(21)Number of the applicationa 2011 0065
(22)Filing date of the application2011.06.16
 Date of filing the request for examination (de fond) 16.06.2011
(71)Name(s) of applicant(s), code of the countryINSTITUTIA PUBLICA UNIVERSITATEA DE STAT DIN MOLDOVA, MD;
(72)Name(s) of inventor(s), code of the countryGULEA Aurelian, MD; TAPCOV Victor, MD; BIRSA Mihail, RO; GINJU Dumitru, RO; JALBA Angela, MD; GRAUR Vasile, MD; JULEA Felicia, MD;
(73)Name(s) of owner(s), code of the countryUNIVERSITATEA DE STAT DIN MOLDOVA, MD;
(54)Title of the inventionInhibitor of human myeloid leukemia based on {bis[2-(3,5-dibrom-2-hydroxyphenyl)-2-oxoethyl-piperidin-1-carbodithioato(1-)-O,O′]copper}
(13)Kind-of-document code
C1, BOPI 07/2013
B1, BOPI 12/2012
(51)International Patent Classification C07F 1/08 (2006.01); C07C 49/78 (2006.01); C07C 49/807 (2006.01); C07C 49/92 (2006.01); C07C 333/22 (2006.01); A61K 31/30 (2006.01); A61K 31/055 (2006.01); A61K 31/27 (2006.01); A61P 35/02 (2006.01); C07C 45/77 (2006.01);
(19)CountryMD
(45)Date of publication of patent granting decision:2012.12.31
(47)Date of issuance of patent2013.07.31
 Substantive examiner(s)JOVMIR Tudor
 Payment for maintenance up to the date2016.06.16
 Date of patent termination2016.06.16
 Date of publication of the termination of patent, with the right of restoration2017.02.28
 Date of publication of the termination of patent, without the right of restoration2018.01.31
Up
/inventions/Details.aspx?id=a%202011%200065